Sulmazole
Sulmazole is a cardiotonic drug.[1] Sulmazole has the chemical formula C14H13N3O2S[2] and a molecular weight of 287.34 g/mol.[2]
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.070.348 |
Chemical and physical data | |
Formula | C14H13N3O2S |
Molar mass | 287.34 g·mol−1 |
3D model (JSmol) | |
SMILES
|
Sulmazole has been shown to improve cardiac index and reduce pulmonary capillary wedge pressure without significant changes in a person's heart rate or arterial pressure.[3] Sulmazole inhibits the A1 adenosine receptor and functionally blocks Gi, an inhibitory regulator.[1] Sulmazole is also a phosphodiesterase inhibitor.[3] Sulmazole is classified as an imidazopyridine and a sulfoxide.[2] Sulmazole can be taken intravenously or orally.[3] Side effects from sulmazole include blurring vision and temporary color blindness.[3]
References
- Parsons WJ, Ramkumar V, Stiles GL (April 1988). "The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi". Molecular Pharmacology. 33 (4): 441–8. PMID 3128727.
- PubChem. "Sulmazole". pubchem.ncbi.nlm.nih.gov. Retrieved 2019-09-30.
- "NCATS Inxight: Drugs — SULMAZOLE". drugs.ncats.io. Retrieved 2019-09-30.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.